Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03085420
Other study ID # CIN1604
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date May 3, 2017
Est. completion date October 21, 2018

Study information

Verified date November 2018
Source Shriners Hospitals for Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to collect information about how often an abnormal heart beat happens in children who have been burned.


Description:

The investigators hope to learn the following:

- If heart arrhythmias are more common in children with a large burn injury than in children with a small burn injury.

- The difference in development of a heart arrhythmia after a large burn injury by comparing information from children with large burns who do and do not develop a heart arrhythmia.

- A better understanding of the length of a hospital stay, the number of operations, and the number of care complications in patients with heart arrhythmias after a burn injury.


Recruitment information / eligibility

Status Terminated
Enrollment 10
Est. completion date October 21, 2018
Est. primary completion date October 21, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria:

Pediatric burn patients from age 0 - 18 who have sustained a burn injury will be eligible for this study.

Group 1 will consist of patients with =30% TBSA burn injury. Group 2 will consist of patients with <30% TBSA burn injury who develop a cardiac abnormality.

Exclusion Criteria:

Patients with pre-existing cardiac disorder, desquamative skin disorders and electrical injury.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Echocardiogram
A baseline Echocardiogram test (ECHO) will be done one week from admission and monthly (+/- 1 week) or as ordered by a cardiologist.

Locations

Country Name City State
United States Shriners Hospitals for Children Cincinnati Ohio

Sponsors (1)

Lead Sponsor Collaborator
Shriners Hospitals for Children

Country where clinical trial is conducted

United States, 

References & Publications (3)

Guillory AN, Clayton RP, Herndon DN, Finnerty CC. Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models. Int J Mol Sci. 2016 Jan 2;17(1). pii: E53. doi: 10.3390/ijms17010053. Review. — View Citation

Howard TS, Hermann DG, McQuitty AL, Woodson LC, Kramer GC, Herndon DN, Ford PM, Kinsky MP. Burn-induced cardiac dysfunction increases length of stay in pediatric burn patients. J Burn Care Res. 2013 Jul-Aug;34(4):413-9. doi: 10.1097/BCR.0b013e3182685e11. — View Citation

Mak GZ, Hardy AR, Meyer RA, Kagan RJ. Reversible cardiomyopathy after severe burn injury. J Burn Care Res. 2006 Jul-Aug;27(4):482-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of cardiac dysfunction in pediatric burn patients Results of echocardiograms will be compared between patients with cardiac dysfunction versus those without cardiac dysfunction. Through study completion up to 4 years after hospital discharge.
Secondary Acute care hospital length of stay Hospital length of stay (admission date to discharge date) will be compared between participants with cardiac dysfunction versus participants without cardiac dysfunction. Hospital admission to discharge (average of 1 day per %TBSA burn - example 30 days for a 30% TBSA burn injury).
See also
  Status Clinical Trial Phase
Completed NCT02320539 - MicroRNA Diagnostics in Subarachnoid Hemorrhage 2 N/A
Recruiting NCT05806138 - A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction Phase 2
Terminated NCT04433546 - Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). Phase 2
Recruiting NCT03790943 - Cardiac Dysfunction in Childhood Cancer Survivors
Completed NCT02581280 - Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)
Recruiting NCT05659589 - Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury N/A
Completed NCT03866564 - Football Players Health Study In Person Assessments Study
Recruiting NCT02144766 - Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block Phase 4